Late postnatal systemic steroids predispose to retinopathy of prematurity in very-low-birth-weight infants: A comparative study

Acta Paediatrica, International Journal of Paediatrics

Volumn 97, Issue 3, 2008, Pages 322-326

  Smolkin, Tatiana ^a,b   Steinberg, Maya ^a   Sujov, Polo ^a,b   Mezer, Eedy ^a,b   Tamir, Ada ^a,b   Makhoul, Imad R ^a,b,c  

^a MEYER CHILDREN S HOSPITAL   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Bronchopulmonary dysplasia; High frequency ventilation; Prematurity; Retinopathy of prematurity; Steroids

Indexed keywords

BETAMETHASONE; DEXAMETHASONE; LUNG SURFACTANT; STEROID;

ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DRUG SUBSTITUTION; GESTATIONAL AGE; HIGH FREQUENCY OSCILLATION; HOSPITALIZATION; HUMAN; HYPEROXIA; INFANT; LOGISTIC REGRESSION ANALYSIS; LUNG DYSPLASIA; MORBIDITY; OXYGEN THERAPY; PERINATAL PERIOD; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; RISK FACTOR; SYSTEMIC THERAPY; UNIVARIATE ANALYSIS; VERY LOW BIRTH WEIGHT;

BETAMETHASONE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; REGRESSION ANALYSIS; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; STEROIDS;

EID: 41949087372     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2008.00629.x     Document Type: Article

References (30)

1. Liu PM, Fang PC, Huang CB, Kou HK, Chung MY, Yang YH, et al. Risk factors of retinopathy of prematurity in premature infants weighing less than 1600 g. Am J Perinatol 2005 22 : 115 20.
2. Karna P, Muttineni J, Angell L, Karmaus W. Retinopathy of prematurity and risk factors: a prospective cohort study. BMC Pediatr 2005 5 : 1 8.
3. Balkundi D, Karna P, Angell L. Effect of antenatal and postnatal glucocorticoids (PG) on the severity of retinopathy of prematurity (ROP). Pediatr Res 1996 39 : 193A.
4. Ertl T, Gyarmati J, Gaál V, Szabó I. Relationship between hyperglycemia and retinopathy of prematurity in very low birth weight infants. Biol Neonate 2006 89 : 56 9.
5. Darlow BA, Hutchinson JL, Henderson-Smart DJ, Donoghue DA, Simpson JM, Evans NJ. Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network. Pediatrics 2005 115 : 990 6.
6. Kim TI, Sohn J, Pi SY, Yoon YH. Postnatal risk factors of retinopathy of prematurity. Paediatr Perinat Epidemiol 2004 18 : 130 4.
7. Smith LE. Pathogenesis of retinopathy of prematurity. Semin Neonatol 2003 8 : 469 73.
8. Manzoni P, Maestri A, Leonessa M, Mostert M, Farina D, Gomirato G, et al. Fungal and bacterial sepsis and threshold ROP in preterm very low birth weight neonates. J Perinatol 2006 26 : 23 30.
9. Lala-Gitteau E, Majzoub S, Saliba E, Pisella PJ. Epidemiology for retinopathy of prematurity: risk factors in the Tours hospital (France)]. J Fr Ophtalmol 2007 30 : 366 73.
10. Englert JA, Saunders RA, Purohit D, Hulsey TC, Ebeling M. The effect of anemia on retinopathy of prematurity in extremely low birth weight infants. J Perinatol 2001 21 : 21 6.
11. Holmes JM, Zhang S, Leske DA, Lanier WL. Metabolic acidosis-induced retinopathy in the neonatal rat. Invest Ophthalmol Vis Sci 1999 40 : 804 9.
12. Chen Y, Leske DA, Zhang S, Karger RA, Lanier WL, Holmes JM. Duration of acidosis and recovery determine preretinal neovascularization in the rat model of acidosis-induced retinopathy. Curr Eye Res 2002 24 : 281 8.
13. Holmes JM, Zhang S, Leske DA, Lanier WL. Carbon dioxide-induced retinopathy in the neonatal rat. Curr Eye Res 1998 17 : 608 16.
14. Regev RH, Lusky A, Dolfin T, Litmanovitz I, Arnon S, Reichman B, Israel Neonatal Network. Excess mortality and morbidity among small-for-gestational-age premature infants: a population-based study. J Pediatr 2003 143 : 186 91.
15. Bizzarro MJ, Hussain N, Jonsson B, et al. Genetic susceptibility to retinopathy of prematurity. Pediatrics 2006 118 : 1858 63.
16. Leske DA, Wu J, Mookadam M, Chen Y, Fautsch MP, Holmes JM, et al. The relationship of retinal VEGF and retinal IGF-1 mRNA with neovascularization in an acidosis-induced model of retinopathy of prematurity. Curr Eye Res 2006 31 : 163 9.
17. D'Angio CT, Maniscalco WM, Ryan RM, Avissar NE, Basavegowda K, Sinkin RA. Vascular endothelial growth factor in pulmonary lavage fluid from premature infants: effects of age and postnatal dexamethasone. Biol Neonate 1999 76 : 266 73.
18. Cooke RWI, Drury JA, Mountford R, Clark D. Genetic polymorphisms and retinopathy of prematurity. Invest Ophthal Vis Sci 2004 4 : 1712 15.
19. Mandal K, Drury JA, Clark DI. An unusual case of retinopathy of prematurity. J Perinatol 2007 27 : 315 6.
20. Genzel-Boroviczeny O, MacWilliams S, Von Poblotzki M, Zoppelli L. Mortality and major morbidity in premature infants less than 31 weeks gestational age in the decade after introduction of surfactant. Acta Obstet Gynecol Scand 2006 85 : 68 73.
21. Van Reempts P, Borstlap C, Laroche S, Van der Auwera JC. Early use of high frequency ventilation in the premature neonate. Eur J Pediatr 2003 162 : 219 26.
22. Halliday HL, Ehrenkranz RA, Doyle LW. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infant. Cochrane Database Syst Rev 2003 : CD001145.
23. Halliday HL, Ehrenkranz RA, Doyle LW. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003 : CD001146.
24. Termote J, Schalij-Delfos NE, Donders AR, Cats BP. Do postnatal glucocorticoids and retinopathy of prematurity relate? Am J Perinatol 2000 17 : 291 8.
25. Modanlou HD, Gharraee Z, Hasan J, Waltzman J, Nageotte S, Beharry KD. Ontogeny of VEGF, IGF-I, and GH in neonatal rat serum, vitreous fluid, and retina from birth to weaning. Invest Ophthalmol Vis Sci 2006 47 : 738 44.
26. Skinner AM, Battin M, Solimano A, Daaboul J, Kitson HF. Growth and growth factors in premature infants receiving dexamethasone for bronchopulmonary dysplasia. Am J Perinatol 1997 14 : 539 46.
27. Vento G, Matassa PG, Ameglio F, Capoluongo E, Tortorolo L, Romagnoli C. Effects of early dexamethasone therapy on pulmonary fibrogenic mediators and respiratory mechanics in preterm infants. Eur Cytokine Netw 2002 13 : 207 14.
28. Bhatt AJ, Amin SB, Chess PR, Watkins RH, Maniscalco WM. Expression of vascular endothelial growth factor and Flk-1 in developing and glucocorticoid-treated mouse lung. Pediatr Res 2000 47 : 606 13.
29. Hartnett ME, Martiniuk DJ, Saito Y, Geisen P, Peterson LJ, McColm JR. Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 2006 47 : 4975 82.
30. O'Shea TM, Doyle LW. Perinatal glucocorticoid therapy and neurodevelopmental outcome: an epidemiologic perspective. Semin Neonatol 2001 6 : 293 307.